GABAPENTIN

GABAPENTIN was reported 367915 times

GABAPENTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 289 0.7468
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 268 0.2524
2 NEPHROGENIC ANAEMIA 1020 0.2200
3 DRUG TITRATION ERROR 563 0.2179
4 HYPERPARATHYROIDISM SECONDARY 525 0.2093
5 REBOUND ACID HYPERSECRETION 490 0.1618
6 INFUSION SITE DISCHARGE 276 0.1573
7 TEMPERATURE REGULATION DISORDER 329 0.1475
8 DIABETIC NEUROPATHY 709 0.1431
9 GUN SHOT WOUND 246 0.1296
10 ESSENTIAL HYPERTENSION 226 0.1234
11 ACCIDENTAL DEATH 229 0.1231
12 INFUSION SITE HAEMORRHAGE 388 0.1178
13 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6353 0.1157
14 NEURALGIA 2645 0.1087
15 INFUSION SITE INFECTION 250 0.1075
16 MYOCLONUS 1278 0.1071
17 INTERVERTEBRAL DISC DEGENERATION 987 0.1066
18 END STAGE RENAL DISEASE 1941 0.1063
19 DEVICE INFUSION ISSUE 257 0.1035
20 TRIGEMINAL NEURALGIA 416 0.1034
21 PRE-EXISTING CONDITION IMPROVED 631 0.1010
22 INFUSION SITE PAIN 1297 0.1006
23 INFUSION SITE SWELLING 616 0.0978
24 INFUSION SITE ERYTHEMA 808 0.0957
25 SUSPECTED SUICIDE 441 0.0940
26 BLOOD PHOSPHORUS INCREASED 252 0.0922
27 HYPERTONIC BLADDER 265 0.0917
28 LUMBAR SPINAL STENOSIS 260 0.0889
29 BLOOD PRESSURE DIASTOLIC ABNORMAL 226 0.0888
30 RADICULOPATHY 233 0.0883
31 SPINAL OSTEOARTHRITIS 744 0.0846
32 SLEEP APNOEA SYNDROME 1608 0.0842
33 INFUSION SITE PRURITUS 261 0.0826
34 CHRONIC KIDNEY DISEASE 6281 0.0826
35 NERVE INJURY 864 0.0776
36 FIBROMYALGIA 1887 0.0775
37 HYPOPNOEA 268 0.0771
38 SPINAL STENOSIS 317 0.0767
39 SPINAL COLUMN STENOSIS 360 0.0761
40 METABOLIC ENCEPHALOPATHY 227 0.0756
41 LYMPHOEDEMA 519 0.0750
42 NERVE COMPRESSION 688 0.0745
43 INTERVERTEBRAL DISC DISORDER 315 0.0737
44 IMPAIRED GASTRIC EMPTYING 1004 0.0736
45 COMPLETED SUICIDE 6097 0.0731
46 SEDATION 1910 0.0729
47 FOOD ALLERGY 560 0.0725
48 INTERVERTEBRAL DISC PROTRUSION 1577 0.0721
49 PRODUCT ADMINISTRATION INTERRUPTED 550 0.0700
50 FEELING DRUNK 510 0.0686
51 COORDINATION ABNORMAL 944 0.0676
52 FOETAL DEATH 350 0.0674
53 PERONEAL NERVE PALSY 383 0.0673
54 RESTLESS LEGS SYNDROME 1221 0.0671
55 EXOSTOSIS 592 0.0648
56 SPINAL FUSION SURGERY 261 0.0643
57 NEUROPATHY PERIPHERAL 6097 0.0640
58 THERAPEUTIC PRODUCT EFFECT VARIABLE 248 0.0639
59 IRON DEFICIENCY 287 0.0637
60 EPIGASTRIC DISCOMFORT 249 0.0637
61 BURSITIS 762 0.0627
62 RESPIRATORY DEPRESSION 769 0.0627
63 BACK DISORDER 1019 0.0626
64 BENIGN PROSTATIC HYPERPLASIA 322 0.0623
65 DECREASED INTEREST 367 0.0622
66 SCOLIOSIS 385 0.0621
67 WALKING AID USER 409 0.0620
68 SCIATICA 981 0.0615
69 EUPHORIC MOOD 626 0.0610
70 DYSPHEMIA 268 0.0610
71 SNORING 231 0.0610
72 HYPERLIPIDAEMIA 728 0.0609
73 CARPAL TUNNEL SYNDROME 845 0.0603
74 ATAXIA 709 0.0597
75 MUSCLE SPASTICITY 731 0.0594
76 CONCUSSION 455 0.0587
77 BODY HEIGHT DECREASED 619 0.0578
78 POST-TRAUMATIC STRESS DISORDER 384 0.0572
79 SEASONAL ALLERGY 809 0.0571
80 OBSESSIVE-COMPULSIVE DISORDER 458 0.0570
81 MENTAL STATUS CHANGES 1580 0.0568
82 BALANCE DISORDER 4911 0.0568
83 OSTEOPENIA 849 0.0559
84 SENSORY LOSS 446 0.0553
85 HYPERAESTHESIA 454 0.0552
86 SPINAL DISORDER 516 0.0544
87 MICTURITION URGENCY 621 0.0543
88 FACIAL PAIN 485 0.0543
89 RENAL INJURY 1612 0.0542
90 THINKING ABNORMAL 1009 0.0541
91 MAJOR DEPRESSION 395 0.0540
92 BIPOLAR DISORDER 587 0.0539
93 FOOT FRACTURE 1021 0.0538
94 BRONCHIECTASIS 362 0.0537
95 ANKLE FRACTURE 827 0.0534
96 PERIPHERAL VASCULAR DISORDER 273 0.0529
97 IMMUNODEFICIENCY 788 0.0528
98 ATELECTASIS 509 0.0526
99 JOINT INJURY 1125 0.0526
100 DECUBITUS ULCER 428 0.0525
101 SOMNAMBULISM 343 0.0522
102 OSTEOARTHRITIS 2212 0.0521
103 SKIN ABRASION 246 0.0520
104 APPENDICITIS 485 0.0519
105 SPINAL OPERATION 639 0.0518
106 SEROTONIN SYNDROME 996 0.0518
107 DENTAL CARIES 570 0.0515
108 VITAMIN D DEFICIENCY 501 0.0513
109 DYSLIPIDAEMIA 259 0.0509
110 HYPERVOLAEMIA 250 0.0505
111 BLADDER DISORDER 502 0.0505
112 DRUG USE DISORDER 425 0.0505
113 LIGAMENT SPRAIN 497 0.0502
114 NIGHTMARE 1739 0.0502
115 IMPAIRED DRIVING ABILITY 571 0.0502
116 ROTATOR CUFF SYNDROME 644 0.0501
117 AMNESIA 3260 0.0501
118 URINARY INCONTINENCE 1476 0.0498
119 SOMNOLENCE 9957 0.0494
120 RIB FRACTURE 1016 0.0493
121 MUSCLE TWITCHING 1138 0.0493
122 CARDIAC MURMUR 426 0.0492
123 HYPERSOMNIA 1408 0.0491
124 MULTIPLE SCLEROSIS RELAPSE 3366 0.0491
125 BACK INJURY 531 0.0488
126 MYASTHENIA GRAVIS 393 0.0486
127 DYSARTHRIA 1830 0.0486
128 DRUG TOLERANCE 243 0.0480
129 DYSKINESIA 1938 0.0476
130 OBESITY 758 0.0475
131 DIPLOPIA 1234 0.0475
132 PRESCRIBED OVERDOSE 919 0.0474
133 INCONTINENCE 502 0.0474
134 CYSTITIS 1509 0.0473
135 FALL 15770 0.0473
136 HYPOPHOSPHATAEMIA 350 0.0473
137 ECONOMIC PROBLEM 717 0.0473
138 INCOHERENT 305 0.0471
139 GINGIVAL PAIN 375 0.0471
140 SUICIDAL IDEATION 4291 0.0468
141 GOUT 841 0.0468
142 HEAD INJURY 1483 0.0468
143 PAROSMIA 353 0.0467
144 BRADYPHRENIA 305 0.0467
145 TUBULOINTERSTITIAL NEPHRITIS 872 0.0465
146 ACUTE RESPIRATORY FAILURE 895 0.0465
147 MENISCUS INJURY 286 0.0465
148 HALLUCINATION, VISUAL 969 0.0458
149 TOXIC ENCEPHALOPATHY 231 0.0456
150 HALLUCINATION 3432 0.0455
151 DYSSTASIA 1327 0.0454
152 HYPERKERATOSIS 250 0.0453
153 LIMB INJURY 1230 0.0452
154 DEPRESSION 10273 0.0451
155 NECK PAIN 2517 0.0450
156 FEELING OF BODY TEMPERATURE CHANGE 263 0.0448
157 VITAMIN D DECREASED 383 0.0448
158 SOPOR 592 0.0446
159 MULTIPLE SCLEROSIS 2136 0.0446
160 HIATUS HERNIA 578 0.0446
161 HYPOAESTHESIA 6676 0.0446
162 OSTEOMYELITIS 807 0.0445
163 LIMB DISCOMFORT 1372 0.0443
164 ACUTE KIDNEY INJURY 6734 0.0440
165 BLOOD POTASSIUM DECREASED 1323 0.0440
166 WEIGHT FLUCTUATION 459 0.0438
167 ANAL INCONTINENCE 393 0.0436
168 SKIN LACERATION 474 0.0435
169 CELLULITIS 2195 0.0435
170 MEMORY IMPAIRMENT 5982 0.0435
171 DERMATITIS CONTACT 496 0.0434
172 RHINITIS 350 0.0434
173 HERPES ZOSTER 2494 0.0434
174 NYSTAGMUS 230 0.0433
175 COGNITIVE DISORDER 2020 0.0432
176 RESPIRATORY ARREST 1187 0.0430
177 GAIT DISTURBANCE 8239 0.0430
178 DRUG SCREEN POSITIVE 339 0.0429
179 EYE MOVEMENT DISORDER 293 0.0427
180 BLOOD MAGNESIUM DECREASED 369 0.0427
181 CONFUSIONAL STATE 6907 0.0427
182 RENAL CYST 339 0.0426
183 INADEQUATE ANALGESIA 362 0.0426
184 MIGRAINE 4068 0.0426
185 TROPONIN INCREASED 324 0.0425
186 FLUID RETENTION 2164 0.0425
187 DIVERTICULUM 302 0.0425
188 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2217 0.0424
189 DIZZINESS POSTURAL 412 0.0424
190 RENAL FAILURE 5641 0.0424
191 WRIST FRACTURE 509 0.0424
192 TENDERNESS 442 0.0424
193 MOTOR DYSFUNCTION 432 0.0423
194 ENCEPHALOPATHY 1040 0.0423
195 POSTOPERATIVE WOUND INFECTION 284 0.0420
196 MULTIPLE ALLERGIES 329 0.0419
197 BLOOD URIC ACID INCREASED 242 0.0419
198 TOOTH FRACTURE 462 0.0419
199 UNRESPONSIVE TO STIMULI 1077 0.0417
200 CENTRAL NERVOUS SYSTEM LESION 572 0.0416
201 BLOOD POTASSIUM INCREASED 675 0.0415
202 IMPAIRED QUALITY OF LIFE 597 0.0415
203 HAND FRACTURE 294 0.0415
204 CYST 514 0.0414
205 PSYCHOLOGICAL TRAUMA 357 0.0413
206 LOCALISED INFECTION 1000 0.0413
207 BLOOD PRESSURE DIASTOLIC DECREASED 305 0.0413
208 ANHEDONIA 1084 0.0412
209 SPINAL COMPRESSION FRACTURE 341 0.0412
210 NEPHROPATHY 385 0.0412
211 POST PROCEDURAL INFECTION 335 0.0412
212 OSTEOPOROSIS 1694 0.0411
213 TREMOR 6825 0.0411
214 GASTROOESOPHAGEAL REFLUX DISEASE 3304 0.0410
215 BONE DISORDER 747 0.0410
216 FULL BLOOD COUNT ABNORMAL 433 0.0409
217 MUSCULAR WEAKNESS 4652 0.0409
218 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1965 0.0409
219 ARTERIOSCLEROSIS CORONARY ARTERY 271 0.0409
220 DEPRESSED LEVEL OF CONSCIOUSNESS 1618 0.0409
221 FULL BLOOD COUNT DECREASED 823 0.0408
222 CEREBRAL DISORDER 302 0.0408
223 FORMICATION 284 0.0408
224 ACTIVITIES OF DAILY LIVING IMPAIRED 806 0.0407
225 PAIN IN JAW 1152 0.0406
226 BURNING SENSATION 2849 0.0406
227 URINARY TRACT INFECTION 6913 0.0405
228 ORAL PAIN 904 0.0403
229 BLOOD IRON DECREASED 479 0.0403
230 TYPE 1 DIABETES MELLITUS 243 0.0403
231 DRUG ABUSE 3357 0.0403
232 DISORIENTATION 1595 0.0402
233 MUSCLE STRAIN 348 0.0402
234 MUSCULOSKELETAL CHEST PAIN 622 0.0401
235 BACK PAIN 9333 0.0401
236 WITHDRAWAL SYNDROME 1686 0.0401
237 TEMPERATURE INTOLERANCE 414 0.0401
238 RENAL TUBULAR NECROSIS 393 0.0400
239 NEPHROLITHIASIS 1836 0.0400
240 COELIAC DISEASE 392 0.0399
241 ARTHRITIS 3141 0.0399
242 SUICIDE ATTEMPT 2421 0.0399
243 TOXICITY TO VARIOUS AGENTS 6725 0.0398
244 GAIT INABILITY 1332 0.0398
245 PAIN IN EXTREMITY 11740 0.0398
246 UPPER RESPIRATORY TRACT INFECTION 1841 0.0398
247 MENTAL IMPAIRMENT 963 0.0397
248 APPETITE DISORDER 263 0.0396
249 MUSCLE TIGHTNESS 642 0.0396
250 HYPOKINESIA 573 0.0394
251 DYSGRAPHIA 260 0.0394
252 INCREASED TENDENCY TO BRUISE 363 0.0394
253 PERIPHERAL SWELLING 6078 0.0394
254 HAIR DISORDER 325 0.0394
255 JOINT RANGE OF MOTION DECREASED 528 0.0393
256 FLANK PAIN 368 0.0392
257 BRONCHITIS 2905 0.0392
258 PARANOIA 675 0.0391
259 GLUCOSE TOLERANCE IMPAIRED 231 0.0390
260 NOCTURIA 474 0.0390
261 SPINAL PAIN 457 0.0390
262 RENAL FAILURE CHRONIC 299 0.0388
263 JOINT DISLOCATION 411 0.0388
264 HYPOVOLAEMIA 227 0.0388
265 DRY MOUTH 3147 0.0387
266 DIABETES MELLITUS 2955 0.0387
267 SPEECH DISORDER 2019 0.0385
268 BRADYKINESIA 227 0.0384
269 CARDIOMEGALY 472 0.0383
270 EMPHYSEMA 386 0.0382
271 FOOT DEFORMITY 424 0.0382
272 INITIAL INSOMNIA 392 0.0382
273 MUSCULOSKELETAL DISCOMFORT 657 0.0381
274 HYPERHIDROSIS 4915 0.0381
275 TYPE 2 DIABETES MELLITUS 1284 0.0381
276 TOOTH DISORDER 845 0.0380
277 ORTHOSTATIC HYPOTENSION 660 0.0379
278 SINUS DISORDER 750 0.0378
279 LETHARGY 2178 0.0378
280 BLOOD PRESSURE FLUCTUATION 908 0.0378
281 URINARY RETENTION 1259 0.0377
282 HAEMATOCRIT DECREASED 748 0.0377
283 CONSTIPATION 8225 0.0377
284 UPPER LIMB FRACTURE 751 0.0377
285 UROSEPSIS 347 0.0376
286 AFFECTIVE DISORDER 295 0.0375
287 QUALITY OF LIFE DECREASED 503 0.0375
288 SPINAL FRACTURE 751 0.0374
289 KIDNEY INFECTION 735 0.0374
290 CARDIO-RESPIRATORY ARREST 1563 0.0373
291 DISTURBANCE IN ATTENTION 2015 0.0373
292 IMPAIRED WORK ABILITY 797 0.0372
293 SUBSTANCE ABUSE 303 0.0372
294 IRON DEFICIENCY ANAEMIA 343 0.0371
295 HOSPICE CARE 367 0.0371
296 PELVIC FRACTURE 289 0.0371
297 ARTERIOSCLEROSIS 349 0.0370
298 MOBILITY DECREASED 2659 0.0370
299 PULMONARY MASS 551 0.0370
300 POOR QUALITY SLEEP 796 0.0369
301 DELUSION 574 0.0369
302 TOOTH INFECTION 487 0.0369
303 BEDRIDDEN 485 0.0369
304 BRAIN FOG 577 0.0368
305 POLYP 241 0.0368
306 SKIN ULCER 950 0.0367
307 TOOTH ABSCESS 374 0.0367
308 ROAD TRAFFIC ACCIDENT 1536 0.0367
309 APHASIA 1107 0.0366
310 HYPOXIA 1289 0.0366
311 SENSORY DISTURBANCE 587 0.0365
312 VENTRICULAR FIBRILLATION 406 0.0365
313 MALNUTRITION 408 0.0364
314 MUSCLE SPASMS 6691 0.0364
315 INSOMNIA 9700 0.0364
316 ABNORMAL LOSS OF WEIGHT 248 0.0363
317 DELIRIUM 1260 0.0363
318 MUSCULOSKELETAL DISORDER 691 0.0363
319 DRUG INTOLERANCE 3503 0.0362
320 BRAIN INJURY 363 0.0362
321 TINNITUS 1662 0.0361
322 GRIP STRENGTH DECREASED 318 0.0361
323 DYSPNOEA EXERTIONAL 1359 0.0360
324 FEELING ABNORMAL 8580 0.0358
325 RED BLOOD CELL COUNT DECREASED 1023 0.0357
326 ARTHROPOD BITE 265 0.0357
327 DISSOCIATION 274 0.0357
328 ULCER 568 0.0357
329 DECREASED ACTIVITY 385 0.0357
330 PARAESTHESIA 5602 0.0356
331 ABASIA 879 0.0355
332 ANXIETY 10124 0.0355
333 CARDIOGENIC SHOCK 510 0.0355
334 MENTAL DISORDER 1545 0.0355
335 BLOOD SODIUM DECREASED 669 0.0355
336 HAIR COLOUR CHANGES 441 0.0354
337 LOWER LIMB FRACTURE 680 0.0354
338 EAR PAIN 687 0.0353
339 HEPATIC STEATOSIS 657 0.0352
340 CONTUSION 3393 0.0352
341 BLOOD CALCIUM INCREASED 309 0.0352
342 OXYGEN SATURATION DECREASED 1980 0.0352
343 PAIN 21510 0.0350
344 VERTIGO 2129 0.0349
345 MOVEMENT DISORDER 1119 0.0348
346 MUSCULOSKELETAL STIFFNESS 3051 0.0348
347 STAPHYLOCOCCAL INFECTION 1146 0.0347
348 PANIC ATTACK 1266 0.0347
349 HEMIPARESIS 588 0.0347
350 JOINT EFFUSION 239 0.0346
351 MUSCULOSKELETAL PAIN 1815 0.0346
352 SLEEP DISORDER 2443 0.0346
353 VISION BLURRED 4717 0.0343
354 INCREASED APPETITE 656 0.0343
355 MITRAL VALVE INCOMPETENCE 388 0.0342
356 POST PROCEDURAL COMPLICATION 657 0.0342
357 GASTROENTERITIS VIRAL 617 0.0341
358 DIABETES MELLITUS INADEQUATE CONTROL 605 0.0341
359 ASPIRATION 374 0.0341
360 PERSONALITY CHANGE 317 0.0341
361 DEHYDRATION 4547 0.0341
362 RED BLOOD CELL SEDIMENTATION RATE INCREASED 377 0.0340
363 TRANSIENT ISCHAEMIC ATTACK 1149 0.0340
364 SMALL INTESTINAL OBSTRUCTION 419 0.0340
365 LACERATION 320 0.0340
366 OEDEMA PERIPHERAL 4147 0.0340
367 POLLAKIURIA 1418 0.0340
368 HAEMORRHOIDS 661 0.0339
369 PHARYNGEAL SWELLING 331 0.0338
370 THERMAL BURN 240 0.0338
371 GROIN PAIN 297 0.0338
372 PARALYSIS 484 0.0338
373 TOOTHACHE 611 0.0337
374 ANGER 1140 0.0337
375 BLOOD CHOLESTEROL INCREASED 1568 0.0336
376 LARGE INTESTINE POLYP 233 0.0336
377 CLOSTRIDIUM DIFFICILE COLITIS 356 0.0335
378 DIZZINESS 16709 0.0335
379 PERIPHERAL COLDNESS 459 0.0334
380 CRYING 1214 0.0334
381 WOUND INFECTION 365 0.0333
382 PULMONARY HYPERTENSION 693 0.0332
383 TRICUSPID VALVE INCOMPETENCE 264 0.0332
384 BACTERIAL INFECTION 617 0.0330
385 UPPER-AIRWAY COUGH SYNDROME 272 0.0330
386 SKIN LESION 905 0.0330
387 AGITATION 2422 0.0329
388 PULMONARY CONGESTION 434 0.0329
389 SPUTUM DISCOLOURED 312 0.0329
390 COMA 1565 0.0328
391 EYE PAIN 1852 0.0328
392 FATIGUE 25514 0.0327
393 BLOOD PRESSURE SYSTOLIC INCREASED 637 0.0326
394 INTENTIONAL PRODUCT MISUSE 2859 0.0326
395 PRODUCTIVE COUGH 1557 0.0326
396 PNEUMONIA 10558 0.0326
397 HAIR TEXTURE ABNORMAL 436 0.0326
398 DYSURIA 1198 0.0325
399 CONVULSION 1848 0.0323
400 ORAL CANDIDIASIS 425 0.0322
401 PRODUCT USE IN UNAPPROVED INDICATION 7999 0.0322
402 ASTHENIA 12120 0.0322
403 SKIN INFECTION 361 0.0321
404 CLOSTRIDIUM DIFFICILE INFECTION 701 0.0321
405 CORONARY ARTERY DISEASE 972 0.0321
406 SEPSIS 3576 0.0320
407 THERAPEUTIC RESPONSE UNEXPECTED 1436 0.0320
408 CONTRAINDICATED PRODUCT ADMINISTERED 968 0.0319
409 WEIGHT INCREASED 7151 0.0319
410 BLOOD CALCIUM DECREASED 359 0.0319
411 LOWER GASTROINTESTINAL HAEMORRHAGE 236 0.0319
412 BLOOD ALBUMIN DECREASED 253 0.0319
413 LOSS OF CONSCIOUSNESS 4084 0.0318
414 HYPONATRAEMIA 1795 0.0318
415 MUSCLE DISORDER 258 0.0318
416 AKATHISIA 434 0.0318
417 PHOTOPHOBIA 598 0.0318
418 EATING DISORDER 677 0.0318
419 HEART RATE DECREASED 1115 0.0317
420 PULMONARY THROMBOSIS 346 0.0317
421 SINUS CONGESTION 428 0.0316
422 HALLUCINATION, AUDITORY 503 0.0316
423 MIOSIS 254 0.0316
424 WEIGHT DECREASED 8834 0.0316
425 LYMPHOCYTE COUNT DECREASED 558 0.0315
426 HIP FRACTURE 1014 0.0315
427 DRUG INTERACTION 4998 0.0315
428 FEEDING DISORDER 637 0.0314
429 SINUSITIS 3216 0.0313
430 BLOOD COUNT ABNORMAL 474 0.0312
431 HYPOPHAGIA 799 0.0312
432 HYPERTENSION 6602 0.0311
433 CARDIAC FAILURE CONGESTIVE 2488 0.0309
434 GRAND MAL CONVULSION 285 0.0308
435 MASS 431 0.0308
436 PNEUMONIA ASPIRATION 768 0.0307
437 NIGHT SWEATS 989 0.0307
438 MOOD ALTERED 837 0.0307
439 ACCIDENT 365 0.0305
440 DYSPHAGIA 2901 0.0305
441 FACIAL PARALYSIS 260 0.0305
442 CORONARY ARTERY OCCLUSION 418 0.0305
443 BLOOD TEST ABNORMAL 428 0.0304
444 CHEST PAIN 5641 0.0304
445 SCAR 521 0.0304
446 BLOOD PRESSURE ABNORMAL 604 0.0303
447 NERVOUSNESS 1585 0.0303
448 HYSTERECTOMY 262 0.0302
449 THYROID DISORDER 466 0.0302
450 GASTRITIS 794 0.0301
451 BOWEL MOVEMENT IRREGULARITY 231 0.0301
452 OPTIC NEURITIS 274 0.0301
453 SWELLING 2820 0.0301
454 IMMUNE SYSTEM DISORDER 397 0.0301
455 SEIZURE 3479 0.0301
456 RESPIRATORY TRACT CONGESTION 478 0.0301
457 JOINT SWELLING 3627 0.0300
458 RESTLESSNESS 1098 0.0300
459 SWOLLEN TONGUE 934 0.0299
460 LUNG INFILTRATION 264 0.0299
461 OEDEMA 1619 0.0298
462 ABNORMAL BEHAVIOUR 1182 0.0298
463 ESCHERICHIA INFECTION 245 0.0298
464 BONE PAIN 1744 0.0297
465 IRRITABLE BOWEL SYNDROME 638 0.0297
466 ARTHROPATHY 1653 0.0297
467 COVID-19 PNEUMONIA 351 0.0297
468 MIDDLE INSOMNIA 555 0.0297
469 GLAUCOMA 571 0.0296
470 HYPERCHOLESTEROLAEMIA 286 0.0296
471 HOT FLUSH 2232 0.0296
472 DEPRESSED MOOD 1565 0.0296
473 PSYCHOMOTOR HYPERACTIVITY 491 0.0296
474 FRUSTRATION TOLERANCE DECREASED 239 0.0295
475 HIP ARTHROPLASTY 453 0.0295
476 BLOOD TRIGLYCERIDES INCREASED 522 0.0295
477 FURUNCLE 234 0.0295
478 NODULE 385 0.0295
479 SURGERY 1729 0.0295
480 CATARACT 1752 0.0294
481 THROMBOSIS 2366 0.0294
482 KNEE ARTHROPLASTY 618 0.0293
483 BLOOD DISORDER 235 0.0293
484 LEUKOCYTOSIS 530 0.0293
485 NAUSEA 23171 0.0292
486 TOOTH LOSS 606 0.0292
487 CARDIAC ARREST 2413 0.0292
488 BLOOD CREATININE INCREASED 1907 0.0292
489 HYPERKALAEMIA 1020 0.0291
490 DYSPEPSIA 2858 0.0290
491 HEADACHE 18210 0.0290
492 HEART RATE IRREGULAR 656 0.0290
493 CHOLELITHIASIS 952 0.0290
494 SLUGGISHNESS 296 0.0290
495 HERNIA 561 0.0290
496 THERAPY CESSATION 1488 0.0290
497 INSURANCE ISSUE 442 0.0289
498 MANIA 475 0.0288
499 WOUND 806 0.0288
500 RENAL FAILURE ACUTE 1222 0.0288
501 CANDIDA INFECTION 486 0.0288
502 DECREASED APPETITE 6676 0.0287
503 DYSPHONIA 1679 0.0287
504 JOINT STIFFNESS 753 0.0287
505 FLUID OVERLOAD 416 0.0286
506 DIARRHOEA 18442 0.0285
507 GALLBLADDER DISORDER 509 0.0285
508 POOR VENOUS ACCESS 295 0.0285
509 BODY TEMPERATURE DECREASED 280 0.0284
510 FLUSHING 2890 0.0284
511 POISONING 357 0.0284
512 FEELING COLD 791 0.0284
513 HYPOAESTHESIA ORAL 428 0.0284
514 APHONIA 396 0.0283
515 RESPIRATORY SYNCYTIAL VIRUS INFECTION 247 0.0283
516 TASTE DISORDER 575 0.0283
517 BODY TEMPERATURE INCREASED 578 0.0283
518 ORAL DISCOMFORT 393 0.0283
519 KNEE OPERATION 278 0.0282
520 HEAD DISCOMFORT 499 0.0282
521 MADAROSIS 327 0.0281
522 WHITE BLOOD CELL COUNT DECREASED 3049 0.0281
523 DRUG TOXICITY 383 0.0281
524 IRRITABILITY 1690 0.0281
525 INFLUENZA LIKE ILLNESS 2313 0.0281
526 STOMATITIS 1704 0.0281
527 RHEUMATOID ARTHRITIS 3189 0.0281
528 ASTHMA 3174 0.0281
529 ARTHRALGIA 11665 0.0280
530 CONDITION AGGRAVATED 8527 0.0280
531 RETCHING 597 0.0280
532 INTENTIONAL SELF-INJURY 565 0.0279
533 DIVERTICULITIS 775 0.0279
534 EAR DISCOMFORT 287 0.0279
535 EAR INFECTION 743 0.0279
536 HYPOTENSION 5598 0.0279
537 PULMONARY OEDEMA 1249 0.0279
538 GASTROINTESTINAL INFECTION 250 0.0279
539 ABDOMINAL DISCOMFORT 4678 0.0279
540 SCRATCH 294 0.0278
541 INFLUENZA 3103 0.0278
542 BLOOD PRESSURE INCREASED 4253 0.0278
543 GENERALISED TONIC-CLONIC SEIZURE 460 0.0278
544 RECTAL HAEMORRHAGE 1193 0.0277
545 BLOOD UREA INCREASED 464 0.0277
546 SCAB 316 0.0277
547 RENAL DISORDER 1290 0.0277
548 INTENTIONAL DOSE OMISSION 788 0.0276
549 BLOOD URINE PRESENT 524 0.0276
550 RENAL PAIN 292 0.0275
551 ABDOMINAL PAIN UPPER 5667 0.0275
552 OROPHARYNGEAL PAIN 2547 0.0275
553 HAEMOPTYSIS 766 0.0274
554 LOCAL SWELLING 479 0.0274
555 SYNCOPE 2737 0.0273
556 DRY THROAT 278 0.0273
557 DEEP VEIN THROMBOSIS 1776 0.0273
558 MUSCLE RIGIDITY 326 0.0272
559 PSYCHOTIC DISORDER 804 0.0272
560 DECREASED IMMUNE RESPONSIVENESS 267 0.0272
561 DRY EYE 1357 0.0272
562 GLOMERULAR FILTRATION RATE DECREASED 334 0.0272
563 VIRAL INFECTION 902 0.0271
564 PRODUCT DISTRIBUTION ISSUE 251 0.0270
565 ABNORMAL DREAMS 747 0.0270
566 ABDOMINAL DISTENSION 2822 0.0270
567 PLASMA CELL MYELOMA 1054 0.0270
568 UPPER GASTROINTESTINAL HAEMORRHAGE 454 0.0270
569 PRODUCT DOSE OMISSION IN ERROR 764 0.0270
570 MOOD SWINGS 859 0.0269
571 LABORATORY TEST ABNORMAL 795 0.0269
572 AFFECT LABILITY 259 0.0269
573 RESPIRATORY FAILURE 1962 0.0269
574 PURPURA 238 0.0269
575 SKIN DISCOLOURATION 1236 0.0269
576 OBSTRUCTIVE AIRWAYS DISORDER 299 0.0269
577 ANKYLOSING SPONDYLITIS 354 0.0268
578 BASAL CELL CARCINOMA 419 0.0268
579 PRODUCT DOSE OMISSION 1752 0.0268
580 TRANSFUSION 281 0.0268
581 HEART RATE INCREASED 2654 0.0268
582 IMPAIRED HEALING 877 0.0267
583 HAEMOGLOBIN DECREASED 2740 0.0267
584 DEFORMITY 249 0.0266
585 WHEEZING 1579 0.0266
586 ACCIDENTAL OVERDOSE 973 0.0266
587 FEELING JITTERY 506 0.0265
588 SUPRAVENTRICULAR TACHYCARDIA 254 0.0265
589 INTENTIONAL PRODUCT USE ISSUE 2323 0.0265
590 TOOTH EXTRACTION 330 0.0265
591 ABDOMINAL PAIN 6168 0.0265
592 WHITE BLOOD CELL COUNT INCREASED 1017 0.0265
593 GENERALISED OEDEMA 328 0.0265
594 STATUS EPILEPTICUS 299 0.0264
595 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 452 0.0263
596 OESOPHAGITIS 288 0.0263
597 VOMITING 12365 0.0263
598 AGGRESSION 1313 0.0262
599 AGEUSIA 654 0.0262
600 BLOOD PRESSURE DECREASED 1742 0.0262
601 PARAESTHESIA ORAL 378 0.0262
602 THERAPY NON-RESPONDER 1177 0.0262
603 ILEUS 325 0.0261
604 BRAIN OEDEMA 330 0.0261
605 PNEUMOTHORAX 413 0.0260
606 EYE INFECTION 294 0.0260
607 DRUG EFFECT INCOMPLETE 945 0.0260
608 CHOKING 506 0.0259
609 FEELING HOT 1590 0.0259
610 ASCITES 762 0.0259
611 TENDONITIS 400 0.0258
612 ATRIAL FIBRILLATION 2510 0.0257
613 HEPATOMEGALY 253 0.0257
614 GASTROINTESTINAL PAIN 283 0.0257
615 HYPOGLYCAEMIA 1247 0.0257
616 ERECTILE DYSFUNCTION 659 0.0256
617 COUGH 7194 0.0256
618 FAECES DISCOLOURED 556 0.0256
619 DYSPNOEA 14512 0.0256
620 IMMUNOSUPPRESSION 226 0.0256
621 BLISTER 1437 0.0256
622 RHINORRHOEA 1653 0.0255
623 GASTRIC DISORDER 877 0.0255
624 INFUSION RELATED REACTION 1686 0.0254
625 GASTRIC ULCER 483 0.0254
626 DISABILITY 502 0.0254
627 PRESYNCOPE 617 0.0254
628 NERVOUS SYSTEM DISORDER 791 0.0253
629 EYE DISORDER 833 0.0253
630 ILLNESS 2607 0.0253
631 FLATULENCE 1435 0.0253
632 COLD SWEAT 446 0.0253
633 RESPIRATORY TRACT INFECTION 659 0.0253
634 HYPOKALAEMIA 1167 0.0253
635 SPLENOMEGALY 296 0.0252
636 CHILLS 2962 0.0252
637 VITREOUS FLOATERS 248 0.0252
638 ELECTROLYTE IMBALANCE 293 0.0252
639 NASAL CONGESTION 1480 0.0252
640 MUSCLE ATROPHY 319 0.0252
641 HEPATIC ENZYME INCREASED 1716 0.0251
642 INTESTINAL OBSTRUCTION 948 0.0251
643 CHEST DISCOMFORT 2567 0.0250
644 OCULAR DISCOMFORT 281 0.0250
645 DRUG LEVEL INCREASED 414 0.0250
646 PULMONARY EMBOLISM 2376 0.0250
647 PANCREATITIS 1321 0.0250
648 POLYNEUROPATHY 299 0.0249
649 INFECTION 3614 0.0249
650 FEAR 671 0.0249
651 ABSCESS 398 0.0249
652 PLATELET COUNT INCREASED 325 0.0249
653 VISUAL IMPAIRMENT 3087 0.0249
654 MALAISE 10880 0.0248
655 HAEMATEMESIS 626 0.0247
656 PLATELET COUNT DECREASED 2628 0.0246
657 GASTROINTESTINAL DISORDER 2206 0.0246
658 PALPITATIONS 2883 0.0246
659 THERAPY PARTIAL RESPONDER 384 0.0246
660 INFLAMMATION 1270 0.0246
661 INTENTIONAL OVERDOSE 1574 0.0245
662 RASH ERYTHEMATOUS 1172 0.0245
663 INTERNAL HAEMORRHAGE 280 0.0245
664 COVID-19 4296 0.0245
665 BREAST PAIN 261 0.0244
666 HYPOTONIA 244 0.0244
667 UNEVALUABLE EVENT 1846 0.0244
668 PHARYNGITIS 302 0.0243
669 NASOPHARYNGITIS 4485 0.0243
670 SQUAMOUS CELL CARCINOMA 229 0.0243
671 PRODUCT USE ISSUE 4567 0.0243
672 BLOOD ALKALINE PHOSPHATASE INCREASED 603 0.0243
673 ANAEMIA 4630 0.0243
674 BACTERAEMIA 288 0.0242
675 SKIN HAEMORRHAGE 359 0.0242
676 HYPERGLYCAEMIA 882 0.0242
677 GASTROINTESTINAL HAEMORRHAGE 2020 0.0241
678 CHOLECYSTECTOMY 276 0.0241
679 PROCEDURAL PAIN 670 0.0241
680 ADRENAL INSUFFICIENCY 293 0.0241
681 COAGULOPATHY 402 0.0241
682 THIRST 431 0.0241
683 THROAT TIGHTNESS 652 0.0241
684 FREQUENT BOWEL MOVEMENTS 651 0.0241
685 PANCREATITIS ACUTE 541 0.0240
686 HYPOMAGNESAEMIA 335 0.0240
687 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 247 0.0240
688 HYPOTHYROIDISM 768 0.0240
689 MYALGIA 4088 0.0240
690 AUTOIMMUNE DISORDER 234 0.0240
691 BLOOD GLUCOSE FLUCTUATION 263 0.0240
692 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1706 0.0240
693 TREATMENT NONCOMPLIANCE 1312 0.0240
694 CHROMATURIA 541 0.0239
695 HEPATIC CIRRHOSIS 450 0.0239
696 PARKINSONISM 233 0.0239
697 HYPERCALCAEMIA 295 0.0239
698 SALIVARY HYPERSECRETION 239 0.0239
699 LYMPHADENOPATHY 845 0.0238
700 ALOPECIA 4679 0.0238
701 NEUROTOXICITY 417 0.0238
702 FUNGAL INFECTION 793 0.0238
703 PLEURAL EFFUSION 1441 0.0237
704 DEVICE RELATED INFECTION 364 0.0236
705 PHARMACEUTICAL PRODUCT COMPLAINT 614 0.0236
706 PERICARDIAL EFFUSION 545 0.0235
707 LUNG DISORDER 1155 0.0235
708 PHARYNGITIS STREPTOCOCCAL 254 0.0234
709 ANGINA PECTORIS 670 0.0234
710 SINUS TACHYCARDIA 332 0.0234
711 RASH PRURITIC 1258 0.0232
712 HEREDITARY ANGIOEDEMA 249 0.0232
713 SEXUAL DYSFUNCTION 272 0.0232
714 SINUS BRADYCARDIA 224 0.0232
715 DYSGEUSIA 1718 0.0231
716 EPISTAXIS 1729 0.0231
717 OFF LABEL USE 20231 0.0231
718 DRUG WITHDRAWAL SYNDROME 2010 0.0229
719 BLINDNESS UNILATERAL 323 0.0229
720 PRODUCT TASTE ABNORMAL 310 0.0229
721 ELECTROCARDIOGRAM QT PROLONGED 822 0.0228
722 PSORIATIC ARTHROPATHY 927 0.0228
723 DRUG INEFFECTIVE 30073 0.0228
724 TACHYCARDIA 2026 0.0228
725 DEVICE OCCLUSION 320 0.0227
726 BRADYCARDIA 1205 0.0227
727 DISCOMFORT 1386 0.0227
728 PETECHIAE 237 0.0227
729 PHOTOSENSITIVITY REACTION 375 0.0227
730 RENAL IMPAIRMENT 1903 0.0226
731 LIP SWELLING 754 0.0226
732 ADVERSE DRUG REACTION 2033 0.0226
733 THROAT IRRITATION 1014 0.0226
734 BLOOD GLUCOSE DECREASED 1085 0.0226
735 PULMONARY ARTERIAL HYPERTENSION 327 0.0225
736 SWELLING FACE 1469 0.0225
737 DEMENTIA 630 0.0225
738 EMOTIONAL DISORDER 694 0.0225
739 DIABETIC KETOACIDOSIS 539 0.0224
740 THERAPY INTERRUPTED 1603 0.0224
741 LOWER RESPIRATORY TRACT INFECTION 1020 0.0224
742 RESPIRATORY DISTRESS 618 0.0224
743 HAEMATOMA 579 0.0223
744 HUNGER 311 0.0223
745 VASCULITIS 259 0.0222
746 PHARYNGEAL OEDEMA 342 0.0222
747 CEREBROVASCULAR ACCIDENT 3763 0.0222
748 MULTIPLE FRACTURES 364 0.0221
749 SKIN DISORDER 738 0.0221
750 GINGIVAL BLEEDING 302 0.0221
751 SKIN CANCER 476 0.0221
752 PYREXIA 7622 0.0220
753 MOUTH ULCERATION 464 0.0220
754 DEVICE FAILURE 335 0.0220
755 LIVER DISORDER 975 0.0220
756 MYDRIASIS 282 0.0220
757 SECRETION DISCHARGE 275 0.0219
758 LACRIMATION INCREASED 663 0.0219
759 SYNOVITIS 394 0.0218
760 DRUG EFFECT DECREASED 1175 0.0218
761 MEDICATION ERROR 1211 0.0218
762 CHOLECYSTITIS 259 0.0217
763 PRODUCT DOSE OMISSION ISSUE 6377 0.0217
764 HYPOACUSIS 932 0.0216
765 ADVERSE REACTION 287 0.0216
766 VENTRICULAR TACHYCARDIA 357 0.0216
767 CARDIOMYOPATHY 319 0.0216
768 RHABDOMYOLYSIS 900 0.0216
769 HAEMATURIA 739 0.0216
770 PRODUCT USE COMPLAINT 339 0.0215
771 ASPARTATE AMINOTRANSFERASE INCREASED 1140 0.0214
772 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 364 0.0214
773 DRUG WITHDRAWAL SYNDROME NEONATAL 317 0.0214
774 INTERNATIONAL NORMALISED RATIO INCREASED 610 0.0214
775 LIVER FUNCTION TEST INCREASED 458 0.0213
776 MYOCARDIAL ISCHAEMIA 242 0.0212
777 PRESCRIBED UNDERDOSE 424 0.0212
778 WRONG TECHNIQUE IN DRUG USAGE PROCESS 772 0.0212
779 GASTROENTERITIS 310 0.0212
780 INJURY 1493 0.0212
781 HAEMATOCHEZIA 1168 0.0211
782 TENDON RUPTURE 261 0.0211
783 RASH MACULAR 739 0.0211
784 SEPTIC SHOCK 919 0.0211
785 RASH PAPULAR 473 0.0211
786 METABOLIC ACIDOSIS 674 0.0211
787 CARDIAC DISORDER 1971 0.0210
788 MACULAR DEGENERATION 251 0.0210
789 BLINDNESS 855 0.0210
790 EPILEPSY 641 0.0209
791 HYPERSENSITIVITY 3890 0.0209
792 NEUROLEPTIC MALIGNANT SYNDROME 248 0.0209
793 MULTIPLE ORGAN DYSFUNCTION SYNDROME 592 0.0209
794 APATHY 304 0.0208
795 RESPIRATORY DISORDER 623 0.0208
796 INTENTIONAL DRUG MISUSE 435 0.0208
797 RASH 9063 0.0208
798 VISUAL ACUITY REDUCED 688 0.0207
799 METASTASES TO BONE 339 0.0206
800 ORAL HERPES 403 0.0206
801 TREATMENT FAILURE 1702 0.0205
802 NEOPLASM 236 0.0205
803 PRURITUS 7889 0.0205
804 MALIGNANT MELANOMA 275 0.0205
805 DRUG DOSE OMISSION 3377 0.0204
806 EYE SWELLING 758 0.0204
807 TARDIVE DYSKINESIA 574 0.0203
808 SUBDURAL HAEMATOMA 290 0.0202
809 GLYCOSYLATED HAEMOGLOBIN INCREASED 511 0.0202
810 LIVER FUNCTION TEST ABNORMAL 588 0.0202
811 DIALYSIS 286 0.0201
812 FEMUR FRACTURE 624 0.0201
813 FRACTURE 381 0.0201
814 SARS-COV-2 TEST POSITIVE 265 0.0200
815 DEAFNESS 520 0.0199
816 LYMPHOPENIA 281 0.0198
817 INJECTION SITE INDURATION 257 0.0198
818 METASTASES TO LUNG 229 0.0198
819 PULMONARY FIBROSIS 380 0.0198
820 SYSTEMIC LUPUS ERYTHEMATOSUS 702 0.0198
821 LEUKOPENIA 988 0.0197
822 DYSTONIA 383 0.0197
823 DRUG EFFECT LESS THAN EXPECTED 292 0.0197
824 OVERDOSE 4251 0.0197
825 PRURITUS GENERALISED 424 0.0196
826 HYPOCALCAEMIA 371 0.0196
827 THROMBOCYTOPENIA 2190 0.0196
828 THERAPEUTIC RESPONSE SHORTENED 648 0.0195
829 PANCYTOPENIA 1091 0.0195
830 MYOCARDIAL INFARCTION 3387 0.0194
831 COLITIS 736 0.0194
832 SKIN FISSURES 379 0.0194
833 BLOOD GLUCOSE ABNORMAL 357 0.0193
834 ALANINE AMINOTRANSFERASE INCREASED 1181 0.0192
835 ANAPHYLACTIC REACTION 1061 0.0192
836 PRODUCT PRESCRIBING ERROR 457 0.0192
837 LUNG INFECTION 297 0.0191
838 INJECTION SITE MASS 706 0.0191
839 HEPATITIS C 228 0.0189
840 EYE HAEMORRHAGE 252 0.0189
841 ACUTE MYOCARDIAL INFARCTION 556 0.0188
842 GENERAL PHYSICAL HEALTH DETERIORATION 2169 0.0187
843 THERAPEUTIC PRODUCT EFFECT DECREASED 839 0.0187
844 PALLOR 503 0.0185
845 RASH GENERALISED 478 0.0184
846 DERMATITIS ALLERGIC 231 0.0183
847 ANOREXIA 236 0.0183
848 HOSPITALISATION 2793 0.0182
849 PRODUCT PHYSICAL ISSUE 365 0.0181
850 PSORIASIS 2356 0.0180
851 PROSTATIC SPECIFIC ANTIGEN INCREASED 248 0.0180
852 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1268 0.0178
853 URTICARIA 2981 0.0178
854 GLOSSODYNIA 398 0.0178
855 EMOTIONAL DISTRESS 2152 0.0178
856 SNEEZING 398 0.0177
857 PRODUCT AVAILABILITY ISSUE 403 0.0177
858 TACHYPNOEA 240 0.0176
859 ABDOMINAL PAIN LOWER 446 0.0176
860 PRODUCT ADHESION ISSUE 630 0.0176
861 ALTERED STATE OF CONSCIOUSNESS 379 0.0175
862 EYE IRRITATION 1002 0.0174
863 FEBRILE NEUTROPENIA 1150 0.0173
864 DRUG PRESCRIBING ERROR 333 0.0173
865 BLOOD GLUCOSE INCREASED 3259 0.0173
866 LACTIC ACIDOSIS 560 0.0173
867 PRODUCT SUBSTITUTION ISSUE 993 0.0172
868 EJECTION FRACTION DECREASED 268 0.0172
869 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3095 0.0172
870 TOXIC EPIDERMAL NECROLYSIS 260 0.0171
871 PRODUCT ADMINISTRATION ERROR 346 0.0171
872 ERUCTATION 325 0.0168
873 PAIN OF SKIN 452 0.0168
874 ERYTHEMA 3449 0.0168
875 CYANOSIS 262 0.0166
876 DISEASE PROGRESSION 1967 0.0166
877 ARRHYTHMIA 787 0.0166
878 ILL-DEFINED DISORDER 1006 0.0165
879 MELAENA 363 0.0165
880 HEPATITIS 422 0.0165
881 OSTEONECROSIS 538 0.0164
882 COLON CANCER 244 0.0164
883 NEUTROPHIL COUNT DECREASED 667 0.0163
884 BONE DENSITY DECREASED 512 0.0163
885 OSTEONECROSIS OF JAW 404 0.0163
886 DERMATITIS 342 0.0163
887 PELVIC PAIN 296 0.0163
888 COMPLICATION ASSOCIATED WITH DEVICE 236 0.0162
889 SKIN EXFOLIATION 1369 0.0162
890 CIRCULATORY COLLAPSE 275 0.0161
891 PNEUMONITIS 438 0.0161
892 BLOOD CREATINE PHOSPHOKINASE INCREASED 462 0.0160
893 GAMMA-GLUTAMYLTRANSFERASE INCREASED 354 0.0160
894 INJECTION SITE REACTION 1095 0.0159
895 SHOCK 363 0.0158
896 METASTASES TO LIVER 277 0.0157
897 ECZEMA 823 0.0157
898 OCULAR HYPERAEMIA 743 0.0156
899 EYE PRURITUS 524 0.0156
900 HEPATIC FAILURE 469 0.0155
901 NEOPLASM PROGRESSION 539 0.0155
902 ANOSMIA 224 0.0155
903 BLOOD BILIRUBIN INCREASED 418 0.0155
904 ACUTE RESPIRATORY DISTRESS SYNDROME 273 0.0154
905 CARDIAC FAILURE 1239 0.0154
906 THERAPEUTIC RESPONSE DECREASED 934 0.0154
907 EXPOSURE DURING PREGNANCY 954 0.0153
908 PRODUCT PRESCRIBING ISSUE 334 0.0153
909 CARDIOVASCULAR DISORDER 387 0.0152
910 HAEMORRHAGE 1586 0.0152
911 NEUTROPENIA 2046 0.0150
912 INJECTION SITE BRUISING 1190 0.0149
913 FACE OEDEMA 251 0.0149
914 CEREBRAL HAEMORRHAGE 531 0.0148
915 CHOLESTASIS 284 0.0148
916 ADVERSE EVENT 1362 0.0148
917 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 343 0.0147
918 C-REACTIVE PROTEIN INCREASED 532 0.0146
919 CONJUNCTIVITIS 269 0.0145
920 SICKLE CELL ANAEMIA WITH CRISIS 228 0.0145
921 DRUG DEPENDENCE 2285 0.0142
922 EXTRAPYRAMIDAL DISORDER 350 0.0141
923 DRUG ERUPTION 249 0.0140
924 DRY SKIN 1874 0.0140
925 MUCOSAL INFLAMMATION 359 0.0137
926 APPLICATION SITE PAIN 302 0.0137
927 DISEASE RECURRENCE 651 0.0137
928 DRUG ADMINISTRATION ERROR 419 0.0136
929 RASH MACULO-PAPULAR 299 0.0134
930 PRODUCT QUALITY ISSUE 1815 0.0133
931 TRANSAMINASES INCREASED 296 0.0133
932 INJECTION SITE ERYTHEMA 1648 0.0133
933 INJECTION SITE PRURITUS 888 0.0132
934 INJECTION SITE WARMTH 271 0.0132
935 DEATH 11322 0.0131
936 INJECTION SITE RASH 403 0.0131
937 NEEDLE ISSUE 380 0.0130
938 STEVENS-JOHNSON SYNDROME 290 0.0130
939 EXPIRED PRODUCT ADMINISTERED 432 0.0130
940 INJECTION SITE PAIN 3985 0.0130
941 PROTEINURIA 245 0.0129
942 INJECTION SITE URTICARIA 316 0.0129
943 NEOPLASM MALIGNANT 856 0.0128
944 MALIGNANT NEOPLASM PROGRESSION 1308 0.0128
945 UNDERDOSE 932 0.0128
946 COLITIS ULCERATIVE 566 0.0127
947 ISCHAEMIC STROKE 224 0.0125
948 DEVICE DISLOCATION 543 0.0125
949 INCORRECT DRUG ADMINISTRATION DURATION 350 0.0124
950 ANGIOEDEMA 550 0.0124
951 AGRANULOCYTOSIS 231 0.0124
952 DEVICE ISSUE 1107 0.0123
953 APPLICATION SITE ERYTHEMA 322 0.0123
954 LIVER INJURY 298 0.0121
955 INCORRECT DOSE ADMINISTERED 2750 0.0120
956 PRODUCT DISPENSING ERROR 261 0.0120
957 INJECTION SITE SWELLING 900 0.0117
958 JAUNDICE 306 0.0114
959 LUNG NEOPLASM MALIGNANT 462 0.0112
960 ANAPHYLACTIC SHOCK 288 0.0112
961 DEVICE MALFUNCTION 775 0.0110
962 INJECTION SITE HAEMORRHAGE 880 0.0110
963 APPLICATION SITE PRURITUS 248 0.0109
964 DEVICE LEAKAGE 468 0.0108
965 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2186 0.0108
966 CEREBRAL INFARCTION 263 0.0108
967 FOETAL EXPOSURE DURING PREGNANCY 870 0.0107
968 DRUG-INDUCED LIVER INJURY 331 0.0105
969 HEPATOTOXICITY 233 0.0105
970 EXTRA DOSE ADMINISTERED 413 0.0102
971 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 259 0.0101
972 VAGINAL HAEMORRHAGE 429 0.0099
973 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 272 0.0093
974 PREMATURE BABY 269 0.0089
975 SKIN BURNING SENSATION 639 0.0089
976 INTERSTITIAL LUNG DISEASE 430 0.0089
977 MATERNAL EXPOSURE DURING PREGNANCY 759 0.0085
978 DERMATITIS ATOPIC 444 0.0084
979 ACNE 613 0.0081
980 SKIN IRRITATION 370 0.0081
981 BREAST CANCER 706 0.0076
982 HEPATIC FUNCTION ABNORMAL 257 0.0069
983 ABORTION SPONTANEOUS 270 0.0067
984 NO ADVERSE EVENT 1195 0.0066
985 DEVICE USE ERROR 229 0.0066
986 DEVICE BREAKAGE 246 0.0061
987 ACCIDENTAL EXPOSURE TO PRODUCT 617 0.0060
988 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 268 0.0057
989 PRODUCT STORAGE ERROR 425 0.0048
990 DEVICE DIFFICULT TO USE 296 0.0045
991 DEPENDENCE 231 0.0042
992 PROSTATE CANCER 309 0.0038
993 DRUG DOSE OMISSION BY DEVICE 247 0.0032